New Therapeutic Agents in Thrombosis and Thrombolysis
eBook - ePub

New Therapeutic Agents in Thrombosis and Thrombolysis

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

New Therapeutic Agents in Thrombosis and Thrombolysis

About this book

As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Edition is a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for trea

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access New Therapeutic Agents in Thrombosis and Thrombolysis by Jane E. Freedman,Joseph Loscalzo in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2016
eBook ISBN
9781040172469
Topic
Medicine
Subtopic
Cardiology

Table of contents

  1. Cover Page
  2. Halftitle Page
  3. Title Page
  4. Series Page
  5. Copyright Page
  6. Introduction
  7. Preface
  8. Table of Contents
  9. About the Contributors
  10. 1 Overview of Hemostasis and Fibrinolysis
  11. 2 Overview of Platelet-Dependent Thrombosis
  12. 3 Design Issues in Clinical Trials of Thrombolytic and Antithrombotic Agents
  13. 4 Pharmacogenomics and Warfarin Anticoagulation
  14. 5 Pharmacogenomics of Platelet Inhibitors
  15. 6 The Effects of Antiplatelet, Antithrombotic, and Thrombolytic Agents on Inflammation and Circulating Inflammatory Biomarkers
  16. 7 The Role of Platelet Function Testing in the Development of Platelet Inhibitors
  17. 8 The Role of Proteomics and Transcriptomics in the Development of Antithrombotics
  18. 9 Overview of New Anticoagulant Drugs
  19. 10 Anticoagulants for the Treatment of Venous Thromboembolism
  20. 11 Anticoagulation in Acute Coronary Syndromes
  21. 12 Anticoagulation in Pregnancy
  22. 13 Anticoagulants in Cancer
  23. 14 Anticoagulation in Children
  24. 15 New Heparins: Synthetic Pentasaccharides
  25. 16 Treatment of Heparin-Induced Thrombocytopenia
  26. 17 Emerging Links Between Thrombosis, Inflammation, and Angiogenesis: Key Role of Heparin and Low-Molecular-Weight Heparins
  27. 18 Oral Direct Factor Xa Inhibitors
  28. 19 Direct Thrombin Inhibitors
  29. 20 Modulators of the Protein C Pathway
  30. 21 Factor IXa Inhibitors
  31. 22 Contact-Activation Pathways as Targets for New Anticoagulants
  32. 23 Overview of Antiplatelet Therapy
  33. 24 Markers of Platelet Function
  34. 25 Intravenous Glycoprotein IIb/IIIa Antagonists
  35. 26 Inhibitors of Platelet Adhesion: VWF-GP1b/IX and Collagen-GPVI Inhibitors
  36. 27 Three Generations of Thienopyridines: Ticlopidine, Clopidogrel, and Prasugrel
  37. 28 Direct P2Y12 Antagonists
  38. 29 Nitric Oxide Donors as Platelet Inhibitors
  39. 30 The Interrelationship of Thrombin and Platelets—The Protease-Activated Receptor-1
  40. 31 Other Antiplatelet Agents
  41. 32 The Combination of Anticoagulants and Platelet Inhibitors Postcoronary Stent Implantation
  42. 33 Overview of Established and New Thrombolytics
  43. 34 Thrombolysis of Deep Vein Thrombosis
  44. 35 Thrombolysis for Acute Pulmonary Embolism
  45. 36 Acute Thrombolysis in Ischemic Cerebrovascular Disease
  46. 37 Fibrinolysis for Acute Myocardial Infarction
  47. 38 Epilogue: The Evolution of Therapeutic Management of Thrombotic and Cardiovascular Disease
  48. Index